What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Ken Shirabe spends much of his time researching Internal medicine, Hepatocellular carcinoma, Surgery, Gastroenterology and Hepatectomy.
His study explores the link between Internal medicine and topics such as Oncology that cross with problems in Hepatitis C virus.
The concepts of his Hepatocellular carcinoma study are interwoven with issues in Tumor size, Survival rate, Carcinoma, Pathology and Surgical oncology.
His study looks at the intersection of Surgery and topics like Sarcopenia with Transplantation.
The Gastroenterology study which covers Parenteral nutrition that intersects with Sepsis.
He has included themes like Cancer, Complication, Abdominal surgery and Risk factor in his Hepatectomy study.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume (367 citations)
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma (271 citations)
What are the main themes of his work throughout his whole career to date?
Ken Shirabe focuses on Internal medicine, Surgery, Hepatocellular carcinoma, Gastroenterology and Hepatectomy.
His Internal medicine research focuses on Oncology and how it connects with Chemotherapy.
His research integrates issues of Radiology and General surgery in his study of Surgery.
His work in Hepatocellular carcinoma addresses subjects such as Pathology, which are connected to disciplines such as Metastasis.
Ken Shirabe studied Gastroenterology and Hepatitis C that intersect with Hepatitis C virus.
His Liver transplantation research incorporates themes from Liver disease and Immunology.
He most often published in these fields:
- Internal medicine (40.07%)
- Surgery (32.17%)
- Hepatocellular carcinoma (28.80%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (40.07%)
- Cancer research (9.29%)
- Gastroenterology (26.95%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cancer research, Gastroenterology, Surgery and Cancer.
His Oncology research extends to the thematically linked field of Internal medicine.
His Cancer research course of study focuses on Immunohistochemistry and PD-L1.
His Gastroenterology research integrates issues from Multivariate analysis, Incidence, Retrospective cohort study and Esophageal cancer.
His studies deal with areas such as Sarcopenia, Lung cancer and Skeletal muscle as well as Surgery.
His research in Hepatocellular carcinoma tackles topics such as Hepatectomy which are related to areas like Carcinoma.
Between 2017 and 2021, his most popular works were:
- Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. (60 citations)
- Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. (42 citations)
- Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study. (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Ken Shirabe mostly deals with Internal medicine, Cancer research, Gastroenterology, Breast cancer and Cancer.
As part of his studies on Internal medicine, Ken Shirabe frequently links adjacent subjects like Oncology.
The Cancer research study combines topics in areas such as Immunohistochemistry, Pancreatic cancer, Metastasis, Gemcitabine and Surgical oncology.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Hepatocellular carcinoma, Hepatectomy, Carcinoma and Multivariate analysis.
Ken Shirabe conducted interdisciplinary study in his works that combined Hepatocellular carcinoma and Carbon Ion Radiation Therapy.
His Cancer study combines topics from a wide range of disciplines, such as Mutation and Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
